{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:30:46Z","timestamp":1755217846426,"version":"3.43.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.josat.2025.209740","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:23:55Z","timestamp":1749558235000},"page":"209740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association between buprenorphine adherence for opioid use disorder and clinical events and healthcare spending among older patients"],"prefix":"10.1016","volume":"176","author":[{"given":"Olajumoke A.","family":"Olateju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Douglas","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Agency for Healthcare Research and Quality","key":"10.1016\/j.josat.2025.209740_bb0005"},{"issue":"6","key":"10.1016\/j.josat.2025.209740_bb0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.15227","article-title":"Comparison of Medicare advantage vs traditional medicare for health care access, affordability, and use of preventive services among adults with low income","volume":"5","author":"Aggarwal","year":"2022","journal-title":"JAMA Network Open"},{"issue":"9","key":"10.1016\/j.josat.2025.209740_bb0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2217\/cer-2020-0013","article-title":"Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants","volume":"9","author":"Allan","year":"2020","journal-title":"Journal of Comparative Effectiveness Research"},{"issue":"25","key":"10.1016\/j.josat.2025.209740_bb0020","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1016\/j.josat.2025.209740_bb0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behavioral Research"},{"author":"Center for Medicare and Medicaid Services","key":"10.1016\/j.josat.2025.209740_bb0030"},{"year":"2020","series-title":"Understanding Medicare Advantage Plans","author":"Centers for Medicare and Medicaid Services","key":"10.1016\/j.josat.2025.209740_bb5010"},{"issue":"9","key":"10.1016\/j.josat.2025.209740_bb0035","doi-asserted-by":"crossref","first-page":"e2334540","DOI":"10.1001\/jamanetworkopen.2023.34540","article-title":"Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl","volume":"6","author":"Chambers","year":"2023","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.josat.2025.209740_bb0040","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Current Opinion in Psychiatry"},{"issue":"12","key":"10.1016\/j.josat.2025.209740_bb0045","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/pme.12520","article-title":"Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients","volume":"15","author":"Daitch","year":"2014","journal-title":"Pain Medicine (Malden, Mass.)"},{"issue":"9","key":"10.1016\/j.josat.2025.209740_bb5005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.37765\/ajmc.2021.88641","article-title":"Quality, health, and spending in Medicare Advantage and traditional Medicare","volume":"27","author":"DuGoff","year":"2021","journal-title":"The American Journal of Managed Care"},{"issue":"1","key":"10.1016\/j.josat.2025.209740_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550887.2011.642758","article-title":"Effect of buprenorphine dose on treatment outcome","volume":"31","author":"Fareed","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.josat.2025.209740_bb0055","first-page":"51","article-title":"Treatment retention in older versus younger adults with opioid use disorder: A retrospective cohort analysis from a large single center treatment program","volume":"104","author":"Francis","year":"2021","journal-title":"Rhode Island Medical Journal (2013)"},{"year":"2024","series-title":"Medicare Advantage in 2024: Premiums, out-of-pocket limits, supplemental benefits, and prior authorization","author":"Freed","key":"10.1016\/j.josat.2025.209740_bb5015"},{"issue":"6","key":"10.1016\/j.josat.2025.209740_bb0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","article-title":"Strobe reporting guidelines for observational studies | research, methods, statistics | JAMA surgery | JAMA network","volume":"156","author":"Ghaferi","year":"2021","journal-title":"JAMA Surgery"},{"issue":"12","key":"10.1016\/j.josat.2025.209740_bb0065","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamapsychiatry.2022.3118","article-title":"Association between buprenorphine treatment gaps, opioid overdose, and health care spending in US medicare beneficiaries with opioid use disorder","volume":"79","author":"Gibbons","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.josat.2025.209740_bb0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/ADM.0000000000001189","article-title":"Evidence on buprenorphine dose limits: A review","volume":"17","author":"Grande","year":"2023","journal-title":"Journal of Addiction Medicine"},{"issue":"7","key":"10.1016\/j.josat.2025.209740_bb0075","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s11606-021-07130-8","article-title":"Multimorbidity and inpatient utilization among older adults with opioid use disorder in New York City","volume":"37","author":"Han","year":"2022","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"10.1016\/j.josat.2025.209740_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.3385","article-title":"Association of household opioid availability with opioid overdose","volume":"6","author":"Hendricks","year":"2023","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2025.209740_bb5020","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmedr.2023.102494","article-title":"Polysubstance use and post-discharge mortality risk among hospitalized patients with opioid use disorder","volume":"36","author":"Hochstatter","year":"2023","journal-title":"Preventive Medicine Reports"},{"issue":"1","key":"10.1016\/j.josat.2025.209740_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.josat.2025.209740_bb0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2018.10.002","article-title":"A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder","volume":"193","author":"Huhn","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.josat.2025.209740_bb0095","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jamapsychiatry.2022.5159","article-title":"Twenty-year trends in drug overdose fatalities among older adults in the US","volume":"80","author":"Humphreys","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.josat.2025.209740_bb0100","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0376-8716(03)00060-7","article-title":"Buprenorphine: How to use it right","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"10.1016\/j.josat.2025.209740_bb0105","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1016\/S2666-7568(23)00174-5","article-title":"Age-friendly care for older adults with substance use disorder","volume":"4","author":"Jones","year":"2023","journal-title":"The Lancet. Healthy Longevity"},{"issue":"5","key":"10.1016\/j.josat.2025.209740_bb0110","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1176\/ajp.2007.164.5.797","article-title":"A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: A randomized controlled trial","volume":"164","author":"Kakko","year":"2007","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.josat.2025.209740_bb5000","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209139","article-title":"Relationship between medication adherence for opioid use disorder and health care costs and health care events in a claims dataset","volume":"154","author":"Liao","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"1","key":"10.1016\/j.josat.2025.209740_bb0115","first-page":"80","article-title":"Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States\u2014Lo-Ciganic\u20142019\u2014Pharmacoepidemiology and drug safety\u2014Wiley online Library","volume":"28","author":"Lo-Ciganic","year":"2019","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"5","key":"10.1016\/j.josat.2025.209740_bb0120","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/add.13270","article-title":"Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization\u2014PubMed","volume":"111","author":"Lo-Ciganic","year":"2016","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.josat.2025.209740_bb5025","doi-asserted-by":"crossref","first-page":"e2314393","DOI":"10.1001\/jamanetworkopen.2023.14393","article-title":"Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong","volume":"6","author":"Lui","year":"2023","journal-title":"JAMA Network Open"},{"issue":"17","key":"10.1016\/j.josat.2025.209740_bb0125","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/CIRCULATIONAHA.119.040680","article-title":"Using the restricted mean survival time difference as an alternative to the hazard ratio for analyzing clinical cardiovascular studies","volume":"140","author":"McCaw","year":"2019","journal-title":"Circulation"},{"author":"Merative","key":"10.1016\/j.josat.2025.209740_bb0130"},{"issue":"12","key":"10.1016\/j.josat.2025.209740_bb0135","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29676","article-title":"Comparison of rates of overdose and hospitalization after initiation of medication for opioid use disorder in the inpatient vs outpatient setting","volume":"3","author":"Morgan","year":"2020","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1016\/j.josat.2025.209740_bb0140","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jamda.2022.11.023","article-title":"The association of long-term opioid use with health care and home care service use among aged home care clients","volume":"24","author":"M\u00f6rttinen-Vallius","year":"2023","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1016\/j.josat.2025.209740_bb0145","article-title":"Pharmacotherapy for opioid use disorder","author":"National Committee for Quality Assurance","year":"2020","journal-title":"NCQA"},{"year":"2017","series-title":"Behavioral health 2016\u20132017: Technical Report","author":"National Quality Forum (NQF)","key":"10.1016\/j.josat.2025.209740_bb0150"},{"issue":"1","key":"10.1016\/j.josat.2025.209740_bb0155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12874-017-0338-0","article-title":"Double-adjustment in propensity score matching analysis: Choosing a threshold for considering residual imbalance","volume":"17","author":"Nguyen","year":"2017","journal-title":"BMC Medical Research Methodology"},{"key":"10.1016\/j.josat.2025.209740_bb0160","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001458","article-title":"Association between buprenorphine adherence trajectories, health outcomes, and health care costs among Medicaid enrollees","author":"Olateju","year":"2025","journal-title":"Journal of Addiction Medicine"},{"issue":"2","key":"10.1016\/j.josat.2025.209740_bb0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-018-05073-z","article-title":"Identifying adherence barriers to oral endocrine therapy among breast cancer survivors","volume":"174","author":"Paranjpe","year":"2019","journal-title":"Breast Cancer Research and Treatment"},{"issue":"1","key":"10.1016\/j.josat.2025.209740_bb0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2009.07.013","article-title":"Long-term outcomes of office-based buprenorphine\/naloxone maintenance therapy","volume":"106","author":"Parran","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"author":"Pharmacy Quality Alliance","key":"10.1016\/j.josat.2025.209740_bb0175"},{"key":"10.1016\/j.josat.2025.209740_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108317","article-title":"Adherence to buprenorphine: An analysis of prescription drug monitoring program data","volume":"216","author":"Pizzicato","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2025.209740_bb0185","doi-asserted-by":"crossref","first-page":"102","DOI":"10.18553\/jmcp.2016.22.2.102","article-title":"What contributes most to high health care costs? Health care spending in high resource patients","volume":"22","author":"Pritchard","year":"2016","journal-title":"Journal of Managed Care & Specialty Pharmacy"},{"key":"10.1016\/j.josat.2025.209740_bb0190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/SAR.S150253","article-title":"Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder","volume":"9","author":"Ronquest","year":"2018","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.josat.2025.209740_bb0195","unstructured":"Ruetsch, C., Tkacz, J., Nadipelli, V. R., Brady, B., Ronquest, N. A., Hyong, U., & Volpicelli, J. (n.d.) Heterogeneity of nonadherent buprenorphine patients: Subgroup characteristics and outcomes. The American Journal of Managed Care, 23(6), e172-e179."},{"key":"10.1016\/j.josat.2025.209740_bb0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","article-title":"Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees","volume":"95","author":"Samples","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1016\/j.josat.2025.209740_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2025.209740_bb0210","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2165\/00023210-200822110-00005","article-title":"Differences in medication adherence and healthcare resource utilization patterns","volume":"22","author":"Sheehan","year":"2008","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.josat.2025.209740_bb0215","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40263-019-00637-z","article-title":"Buprenorphine treatment for opioid use disorder: An overview","volume":"33","author":"Shulman","year":"2019","journal-title":"CNS Drugs"},{"author":"Substance Abuse and Mental Health Services Administration","key":"10.1016\/j.josat.2025.209740_bb0220"},{"issue":"1","key":"10.1016\/j.josat.2025.209740_bb0225","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.51856","article-title":"Trends and characteristics of buprenorphine-involved overdose deaths prior to and during the COVID-19 pandemic","volume":"6","author":"Tanz","year":"2023","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.josat.2025.209740_bb0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1521-0391.2011.00186.x","article-title":"Compliance with buprenorphine medication-assisted treatment and relapse to opioid use","volume":"21","author":"Tkacz","year":"2012","journal-title":"The American Journal on Addictions"},{"issue":"4","key":"10.1016\/j.josat.2025.209740_bb0235","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jsat.2013.10.014","article-title":"Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patients","volume":"46","author":"Tkacz","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"author":"US Bureau of Labor Statistics","key":"10.1016\/j.josat.2025.209740_bb0240"},{"author":"US Food and Drug Administration","key":"10.1016\/j.josat.2025.209740_bb0245"},{"issue":"4","key":"10.1016\/j.josat.2025.209740_bb0250","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: Introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1016\/j.josat.2025.209740_bb5030","doi-asserted-by":"crossref","first-page":"e2423954","DOI":"10.1001\/jamanetworkopen.2024.23954","article-title":"Opioid Overdose After Medication for Opioid Use Disorder Initiation Following Hospitalization or ED Visit","volume":"7","author":"Weiner","year":"2024","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1016\/j.josat.2025.209740_bb0255","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1176\/appi.ajp.20220456","article-title":"Performance measurement for opioid use disorder medication treatment and care retention","volume":"180","author":"Williams","year":"2022","journal-title":"The American Journal of Psychiatry"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T20:25:18Z","timestamp":1754425518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925001195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":58,"alternative-id":["S2949875925001195"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209740","relation":{},"ISSN":["2949-8759"],"issn-type":[{"type":"print","value":"2949-8759"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between buprenorphine adherence for opioid use disorder and clinical events and healthcare spending among older patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209740"}}